Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
ICG001: A Selective Wnt/β-Catenin Pathway Inhibitor in Trans
2026-07-04
ICG001 empowers researchers to dissect the CBP/β-catenin axis in cancer and fibrosis with precision, enabling robust, reproducible modulation of Wnt signaling. Its selectivity and well-validated protocols unlock new dimensions in disease modeling and therapeutic development.
-
IRF1-PARP12 Axis Impairs Mitophagy in Osteoarthritis Cartila
2026-07-03
This study uncovers how IRF1-driven PARP12 expression promotes cartilage degradation in osteoarthritis by blocking PINK1/Parkin-dependent mitophagy, mediated through ISG15-dependent modification of MFN1/2. The findings clarify a new molecular pathway underlying cartilage catabolism and demonstrate that XAV-939 can attenuate these effects, offering new directions for OA research.
-
High-Throughput Blood-Brain Barrier Model for CNS Drug Scree
2026-07-03
The referenced study introduces a surrogate in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for accurate permeability prediction. This innovation enables high-throughput, physiologically relevant screening of CNS drug candidates, potentially accelerating early-stage development and reducing reliance on animal models.
-
IWR-1-endo: Strategic Use of a Wnt Signaling Inhibitor in Tr
2026-07-02
This article delivers a thought-leadership perspective on leveraging IWR-1-endo—a potent Wnt/β-catenin pathway inhibitor—for translational oncology. It fuses mechanistic insights about Axin-scaffolded destruction complex stabilization with actionable guidance for researchers advancing colorectal cancer and regenerative biology studies. By integrating recent advances in single-nucleus RNA-seq and highlighting APExBIO’s product quality, the discussion empowers teams to move beyond standard workflows and anticipate future cross-domain applications.
-
IWR-1-endo: Potent Wnt Signaling Inhibitor for Advanced Rese
2026-07-02
IWR-1-endo is a nanomolar-potency Wnt signaling inhibitor that blocks β-catenin accumulation by stabilizing Axin destruction complexes. It is validated for disrupting Wnt/β-catenin-driven processes in colorectal cancer and regenerative biology. This article details its mechanism, evidence base, workflow parameters, and limitations for robust experimental design.
-
Murine RNase Inhibitor: Robust RNA Protection for Reliable A
2026-07-01
Explore how Murine RNase Inhibitor (SKU K1046) addresses persistent challenges in RNA degradation prevention for cell viability and molecular assays. This scenario-driven guide provides quantitative, literature-backed insights to enhance reproducibility, sensitivity, and workflow safety, empowering biomedical researchers with validated best practices.
-
Dorsomorphin (Compound C): Advanced AMPK & BMP Assay Solutio
2026-07-01
Dorsomorphin (Compound C) enables precise, dual-pathway modulation for dissecting metabolic and differentiation responses in cellular and animal models. This guide delivers actionable workflows, troubleshooting strategies, and new insights from Wnt-mediated bone anabolism studies. Researchers seeking rigorous AMPK inhibition or BMP pathway modulation will find stepwise protocols and integrative analysis approaches here.
-
Metabolomics Distinguishes Carbapenemase-Producing Enterobac
2026-06-30
This study introduces a metabolomics-driven approach to rapidly identify carbapenemase-producing Enterobacterales (CPE), offering a new diagnostic paradigm beyond conventional culture-based methods. By leveraging LC-MS/MS and machine learning, the research uncovers distinct metabolic signatures linked to resistance phenotypes, with implications for antibiotic stewardship and resistance surveillance.
-
Isoproterenol Sulfate Dihydrate: Illuminating Human SAN Matu
2026-06-30
Explore how Isoproterenol sulfate dihydrate empowers mechanistic dissection of human sinoatrial node (SAN) maturation and neuro-cardiac signaling, leveraging unique insights from advanced assembloid models. This article uniquely connects product biophysics with translational assay design.
-
Epalrestat as a Neuroprotective Aldose Reductase Inhibitor:
2026-06-29
Discover how Epalrestat, a potent aldose reductase inhibitor, advances oxidative stress research and neuroprotection in Parkinson’s disease models. This article offers a deeper mechanistic analysis, clarifying its unique value for translational neuroscience.
-
Hypoxia, Choroid Plexus Disruption, and AMPK in Cognitive De
2026-06-29
This study reveals a mechanistic link between hypoxic exposure, choroid plexus barrier impairment, and cognitive dysfunction in mice. It identifies aberrant AMPK pathway activation as a central trigger for M1 macrophage-driven disruption of the blood-cerebrospinal fluid barrier, highlighting new intervention targets for hypoxia-induced CNS deficits.
-
Vascular Effects of JAK Inhibitors on Endothelial Inflammati
2026-06-28
The reference study systematically compares six JAK inhibitors, including tofacitinib citrate, for their impact on endothelial cell dysfunction and prothrombotic signaling during cytokine-driven inflammation. Findings reveal that while all JAK inhibitors reduce IL-6 release, their effects on adhesion molecules and coagulation pathways differ, informing cardiovascular safety considerations in immune regulation research.
-
Cefazedone (Refosporen): Applied Antibacterial Testing Workf
2026-06-27
Cefazedone (Refosporen) stands out for robust, reproducible antibacterial testing, especially where β-lactamase resistance or challenging Gram-positive infections are critical. This article unpacks practical laboratory protocols, comparative advantages, and troubleshooting strategies that maximize data quality and translational relevance in both in vitro and in vivo workflows.
-
Enhancing Immunoassay Precision with TBST Buffer Workflows
2026-06-26
TBST (Tris-Buffered Saline and Tween 20) sets the benchmark for signal-to-noise ratio enhancement in immunoassays. Explore advanced workflows, troubleshooting tactics, and insights from recent metastasis research that elevate reproducibility in antibody-based detection.
-
Cy5-UTP: Precision RNA Labeling for Advanced FISH and Arrays
2026-06-26
Cy5-UTP (Cyanine 5-UTP) elevates RNA probe synthesis with unmatched sensitivity, streamlining in vitro transcription for FISH and dual-color expression arrays. Explore workflow optimizations, troubleshooting insights, and the integration of reference-driven innovations to maximize your RNA labeling results.